Previous 10 | Next 10 |
Ardelyx (ARDX) shares slide more than 19% during post-market trading after announcing that the Prescription Drug User Fee Act ((PDUFA)) date for tenapanor for the control of serum phosphorus in adult patients with chronic kidney disease ((CKD)) on dialysis has been extende...
Ardelyx Announces Extension of the PDUFA Review Period for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis PR Newswire FREMONT, Calif. and WALTHAM, Mass. , April 29, 2021 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX),...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...
Gainers: [[ERII]] +10.8%. [[ARDX]] +7.3%. [[HEAR]] +6.1%. [[IPAR]] +4.4%. [[ISRG]] +3.8%.Losers: [[NFLX]] -8.8%. [[TCOM]] -8.8%. [[BFIIW]] -5.3%. [[ADV]] -6.5%. [[ROKU]] -4.0%. For further details see: HEAR, ISRG, NFLX and ADV among after-hours movers
Ardelyx Inc. (NASDAQ:ARDX) traded at a new 52-week high today of $8.87. Approximately 1.9 million shares have changed hands today, as compared to an average 30-day volume of 1.4 million shares. Ardelyx Inc. (NASDAQ:ARDX) is currently priced 13.1% above its average consensus analyst price...
Ardelyx Inc. (NASDAQ:ARDX) traded at a new 52-week high today of $9.15. This new high was reached on above average trading volume as 1.9 million shares traded hands, while the average 30-day volume is approximately 1.4 million shares. In the past 52 weeks, shares of Ardelyx Inc. have tra...
Shares of Ardelyx Inc. (NASDAQ:ARDX) traded today at $8.92, eclipsing its 52-week high. So far today approximately 1.9 million shares have been exchanged, as compared to an average 30-day volume of 1.4 million shares. Over the past year, Ardelyx Inc. has traded in a range of $4.96 to $8....
Gainers: Wilhelmina International (WHLM) +25%.Kaleido Biosciences (KLDO) +14%.Ardelyx (ARDX) +14%.PLBY Group (PLBY) +14%.Talis Biomedical (TLIS) +14%.Wah Fu Education (WAFU) +12%.Seelos Therapeutics (SEEL) +11%Inpixon (INPX) +11%.BCTG Acquisition (BCTG) +10%.Ballantyne Strong (...
Gainers: Ardelyx (ARDX) +13%, Liquidia (LQDA) +9%, PPD (PPD) +7%, Inovio Pharmaceuticals (INO) +6%, BiomX (PHGE) +6%.Losers: Zomedica (ZOM) -12%, Affimed (AFMD) -10%, Aesthetic Medical International (AIH) -7%, Galectin Therapeut...
Shares of Ardelyx (NASDAQ: ARDX) were soaring 8.9% as of 2:57 p.m. EDT on Wednesday. The big jump came after the company announced that its Japanese partner, Kyowa Kirin , has begun four late-stage clinical studies evaluating Ardelyx's lead candidate tenapanor in treating hyperp...
News, Short Squeeze, Breakout and More Instantly...
Why The Stock Market Is Down Today Why is the stock market down today? The final week of June and the second quarter has been jam-packed with economic data and inflation-related events. Fed Chair Jerome Powell recently said that the global economy has entered a “new world”...
Ardelyx Announces $20 Million Financing Agreement with HealthCare Royalty Partners PR Newswire HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA ® in the United States in exchange for future hyperphosphatemia royalty payments from ...
Ardelyx Announces FDA Advisory Committee Meeting to Review XPHOZAH® NDA Tentatively Scheduled for November 16, 2022 PR Newswire WALTHAM, Mass. , June 21, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a missio...